AI in Healthcare 5.0: Opportunities and Challenges
DOI:
https://doi.org/10.59890/ijaamr.v2i1.281Keywords:
Precision Medicine, Interoperability, Data Privacy, Ethical AI, Regulatory ComplianceAbstract
The advent of Explainable AI (XAI) in healthcare, often referred to as Healthcare 5.0, presents both significant opportunities and challenges. XAI promises to enhance clinical decision-making by providing transparent and interpretable insights into AI-driven diagnoses and treatment recommendations, thereby increasing trust and adoption among healthcare practitioners. This paper explores the evolving landscape of XAI in healthcare, highlighting its potential to improve patient outcomes, reduce errors, and optimize resource allocation. However, it also addresses the challenges of implementing XAI, including data privacy concerns, regulatory hurdles, and the need for robust validation methods. Balancing these opportunities and challenges is critical for realizing the full potential of XAI in revolutionizing healthcare delivery.
References
A. Meldo, L. Utkin, M. Kovalev, and E. Kasimov, ‘‘The natural language explanation algorithms for the lung cancer computer-aided diagnosis system,’’ Artif. Intell. Med., vol. 108, Aug. 2020, Art. no. 101952.
B. Panigutti, A. Perotti, and D. Pedreschi, ‘‘Doctor XAI: An ontology based approach to black-box sequential data classification explana tions,’’ in Proc. Conf. Fairness, Accountability, Transparency. New York, NY, USA: Association for Computing Machinery, Jan. 2020, pp. 629–639.
Blockchain for Industry 4.0: A Comprehensive Review,IEEE(2022).
C. Xiao, T. Ma, A. B. Dieng, D. M. Blei, and F. Wang, ‘‘Readmission prediction via deep contextual embedding of clinical concepts,’’ PLoS ONE, vol. 13, no. 4, Apr. 2018, Art. no. e0195024.
Challenges to implementing artificial intelligence in healthcare: a qualitative interview study with healthcare leaders in Sweden(2022).
E. Choi, M. T. Bahadori, J. Sun, J. Kulas, A. Schuetz, and W. Stewart, ‘‘RETAIN: An interpretable predictive model for healthcare using reverse time attention mechanism,’’ in Proc. Adv. Neural Inf. Process. Syst., vol. 29, 2016, pp. 1–9.
J. Zhang, K. Kowsari, J. H. Harrison, J. M. Lobo, and L. E. Barnes, ‘‘Patient2Vec: A personalized interpretable deep representation of the longitudinal electronic health record,’’ IEEE Access, vol. 6, pp. 65333–65346, 2018.
L. Pan, G. Liu, et all. ‘‘Devel opment of prediction models using machine learning algorithms for girls with suspected central precocious puberty: Retrospective study,’’ JMIR Med. Informat., vol. 7, no. 1, Feb. 2019, Art. no. e11728.
M. S. Kovalev, L. V. Utkin, and E. M. Kasimov, ‘‘SurvLIME: A method for explaining machine learning survival models,’’ Knowl.-Based Syst., vol. 203, Sep. 2020, Art. no. 106164.
S. Ghafouri-Fard, M. Taheri, M. D. Omrani, A. Daaee, H. Mohammad Rahimi, and H. Kazazi, ‘‘Application of single-nucleotide polymorphisms in the diagnosis of autism spectrum disorders: A preliminary study with artificial neural networks,’’ J. Mol. Neurosci., vol. 68, no. 4, pp. 515–521, Aug. 2019.
Sensors and healthcare 5.0: transformative shift in virtual care through emerging digital health technologies(2021)
The Internet of Things in Healthcare: Potential Applications and Challenges (2016).
Toward real-time and efficient cardiovascular monitoring for COVID-19 patients by 5G-enabled wearable medical devices: a deep learning approach(2021)
Y. Ming, H. Qu, and E. Bertini, ‘‘RuleMatrix: Visualizing and understand ing classifiers with rules,’’ IEEE Trans. Vis. Comput. Graphics, vol. 25, no. 1, pp. 342–352, Jan. 2019.
Z. Che, S. Purushotham, R. Khemani, and Y. Liu, ‘‘Interpretable deep models for ICU outcome prediction,’’ in Proc. AMIA Annu. Symp. Bethesda, MD, USA: American Medical Informatics Association, 2016, p. 371.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Soham Date, Meenakshi Thalor
This work is licensed under a Creative Commons Attribution 4.0 International License.
